The roles clinicians should play to mitigate HIV spread.

HIV/AIDS is by far one of the most devastating global epidemics that has baffled clinicians and researchers worldwide. Strides to mitigate the catastrophic effects that troubled those living with HIV in the 20th century are apparent. They stem from the meticulous research into understanding the virus to ongoing trials to find an HIV vaccine. Various ...

Read More

The NADIA trial data findings: they are commendable.

If you aren’t aware yet, the NADIA trial team (Nucleosides And Darunavir/Dolutegravir In Africa) published their data findings in one of the world’s most prestigious journals – the New England Journal of Medicine (NEJM). It is a feat worth celebrating for the Infectious Diseases Institute (IDI) at the gallant Makerere University, Uganda, and Africa at ...

Read More

Should we screen for kidney disease among people living with HIV taking Tenofovir-based ART?

In our article today, we use the findings from a recent paper by Nyende et al. published in BMC Nephrology to ascertain whether we (health care providers) should screen for kidney disease among people living with HIV taking Tenofovir-based ART. Kidney disease, one of several non-communicable diseases, is on the rise worldwide. At the same ...

Read More
Enable Notifications OK No thanks